rss
Br J Ophthalmol 2005;89:74-80 doi:10.1136/bjo.2004.051540
  • Clinical science
    • Extended reports

Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema

  1. J K Luttrull1,
  2. D C Musch2,
  3. M A Mainster3
  1. 1Private practice, Ventura, CA, USA
  2. 2Departments of Ophthalmology and Visual Sciences and Epidemiology, Schools of Medicine and Public Health, University of Michigan, Ann Arbor, MI, USA
  3. 3Department of Ophthalmology, University of Kansas School of Medicine, Kansas City, Kansas
  1. Correspondence to: Jeffrey K Luttrull MD 3160 Telegraph Road, Suite 230, Ventura, CA, 93003, USA; jkluttrullaol.com
  • Accepted 3 June 2004

Abstract

Aim: To report the visual and clinical outcomes of a pilot study of subthreshold diode micropulse (SDM) laser photocoagulation for clinically significant diabetic macular oedema (CSMO).

Methods: The results of infrared (810 nm) SDM laser photocoagulation for CSMO were retrospectively reviewed in 95 eyes of 69 consecutive patients with mild to moderate non-proliferative diabetic retinopathy. The same laser parameters were used for each patient. Only the number of laser applications varied between patients, depending on their macular findings. Primary outcome measures were Snellen visual acuity, fluorescein angiographic leakage, and CSMO status.

Results: Visual acuity was stable or improved in 85% of treated eyes, with a mean follow up of 12.2 months (range 3–29 months). CSMO decreased in 96% and resolved in 79% of treated eyes. No adverse laser events occurred. No laser lesions were detectable ophthalmoscopically or angiographically after treatment, consistent with calculations based on ANSI Z136.1 laser safety standards suggestive of only histologically detectable tissue effects at the laser exposure levels. No laser scarring was observed during the follow up period.

Conclusion: Subthreshold diode micropulse laser photocoagulation minimises chorioretinal damage in the management of CSMO and demonstrates a beneficial effect on visual acuity and CSMO resolution. Prospective studies are needed to fully evaluate this technique.

Footnotes

  • Commercial interests: JKL, none; DCM and MAM, consultants, Iridex, Mountain View, CA, USA.

Responses to this article

  • Subtreshold DMP for CSMO
    • Carsten Framme,
    • Veit-Peter Gabel, MD
    Br J Ophthalmol published online September 14, 2009

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.